Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Baxter Further Expands Halle, Germany Facility to Support BioPharma Solutions’ Cytotoxic Contract Manufacturing Services

    February 26, 2013
    Baxter International Inc.'s BioPharma Solutions business has begun an approximately 1,750 square meter capacity expansion at the company's fill/finish cytotoxic contract manufacturing facility in Halle (Westfalen), Germany. The facilit…

  • Array BioPharma Restructures

    June 14, 2011
    Array BioPharma will restructure in an effort to extend its financial resources to focus on the development of key clinical programs: ARRY-520, a KSP inhibitor for multiple myeloma, ARRY-614, a p38 / Tie-2 inhibitor for myelodysplastic syndrome, and MEK162, a MEK inhibitor for cancer in co-development with Novartis.

  • Laureate Pharma Becomes Biopharma

    February 1, 2011
    New name focuses on biopharma services

  • Vetter, Sentry Biopharma Enter Logistics Pact

    May 4, 2010
    Vetter, a provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement.

  • Sentry BioPharma, CDC Enter Vax Distribution Pact

    February 24, 2010
    The Centers for Disease Control & Prevention (CDC) has selected Sentry BioPharma Services to store and distribute flu vaccine to support its national strategic reserve.

  • Novozymes Biopharma Builds cGMP bHA Facility

    April 27, 2009
    Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.

  • BMS, PDL BioPharma Enter Multiple Myeloma Drug Pact

    August 20, 2008
    Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o…

  • Array BioPharma

    March 18, 2008
    Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs…

  • Tufts Study Finds Pharma/Biopharma Organization Structure Affects Performance

    February 5, 2008
    A recent study by the Tufts Center for the Study of Drug Development found that how drug developers organize their companies affects operational and financial performance. The research, developed by Tufts CSDD and PRTM, an operations management consu…

  • PDL BioPharma Moves Headquarters

    July 7, 2006
    PDL BioPharma, Inc. plans to move its corporate headquarters from Fremont to Redwood City, CA during the third quarter of 2007. PDL has signed long-term leases for two existing buildings that total approximately 450,000 sq.-ft. The new headquarters w…